logo
Select company
Select metric
$ -339.05MOperating Income
VS
Market
3
Sector
5
Industry
5
History
6
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information

Ticker

SNDX

Company Name

SYNDAX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SYNDAX PHARMACEUTICALS INC - Operating Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SNDX - Op. Inc. Historical data
DateOperating Income
6/30/2025$ -339.05M
3/31/2025$ -343.92M
12/31/2024$ -339.67M
9/30/2024$ -321.21M
6/30/2024$ -287.99M
3/31/2024$ -263.45M
12/31/2023$ -229.95M
9/30/2023$ -194.08M
6/30/2023$ -172.87M
3/31/2023$ -160.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) Op. Inc. stands at $ -65.77M.
  • Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average Op. Inc. has been $ -158.7M.
  • The median Op. Inc. for SYNDAX PHARMACEUTICALS INC during this period was $ -156.34M
  • SYNDAX PHARMACEUTICALS INC reached its highest Op. Inc. over the past 5 years at $ 26.22M.
  • The lowest Op. Inc. recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe $ -343.92M

SYNDAX PHARMACEUTICALS INC's Op. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Op. Inc. Benchmarks
CompanyOp. Inc.
NRIX : NURIX THERAPEUTICS INC $ -267.23MURGN : UROGEN PHARMA LTD $ -123.56MTBPH : THERAVANCE BIOPHARMA INC $ -37.2MZVRA : ZEVRA THERAPEUTICS INC $ -119.12MKURA : KURA ONCOLOGY INC $ -219.71MSAGE : SAGE THERAPEUTICS INC $ -324.82MGYRE : GYRE THERAPEUTICS INC $ 9.27MNKTR : NEKTAR THERAPEUTICS $ -100.76MEYPT : EYEPOINT PHARMACEUTICALS INC $ -189.05MZYME : ZYMEWORKS INC $ -82.71M

Definition of Operating Income

[Income Statement] Operating income (income from operations) represents the gross profit [GP] less operating expenses [OpEx]. Operating income doesn’t include interest expenses [IntExp], tax expenses [TaxExp] and other Non-Operating items.

SNDX - Operating Income, Last 5 years

$ -343.92M

Minimum

Mar 31, 2025

$ 26.22M

Maximum

Dec 31, 2021

$ -158.7M

Average

$ -156.34M

Median

Op. Inc. Benchmark Analysis

The chart above depicts the distribution of Op. Inc. for companies in the Total Stock Market. The average Op. Inc. of the companies is $ 26.37M with a standard deviation of $ 130.87M.
The following table provides additional summary stats:
Op. Inc. in the Market:
filtered constituents3.32K
min$ -410.64M
max$ 444.54M
average$ 26.37M
median$ -903K
std$ 130.87M